![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 9/00 | (2006.01) |
A61K 38/18 | (2006.01) | ||
A61K 48/00 | (2006.01) | ||
A61K 9/127 | (2006.01) | ||
A61K 31/7088 | (2006.01) |
(11) | Number of the document | 3703658 |
(13) | Kind of document | T |
(96) | European patent application number | 18811407.8 |
Date of filing the European patent application | 2018-10-31 | |
(97) | Date of publication of the European application | 2020-09-09 |
(45) | Date of publication and mention of the grant of the patent | 2022-05-04 |
(46) | Date of publication of the claims translation | 2022-07-25 |
(86) | Number | PCT/US2018/058541 |
Date | 2018-10-31 |
(87) | Number | WO 2019/089818 |
Date | 2019-05-09 |
(30) | Number | Date | Country code |
201762579671 P | 2017-10-31 | US |
(72) |
HANSSON, Kenny, Mikael , SE
BENENATO, Kerry , US
WÅGBERG, Maria , SE
PÅLSSON, Annika , SE
FRITSCHE-DANIELSON, Regina , SE
|
(73) |
ModernaTX, Inc. ,
200 Technology Square, Cambridge, MA 02139,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Lipidų nanodalelės, skirtos modifikuotos RNR, koduojančios VEGF-A polipeptidą, pristatymui |
LIPID NANOPARTICLES FOR DELIVERING MODIFIED RNA ENCODING A VEGF-A POLYPEPTIDE |
Payment date | Validity (years) | Amount | |
2023-10-19 | 6 | 139.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-10-31 |